Manufacturing News of Note—New cell therapy facility in China

stock market
(Pixabay)

> Chinese biotech Cellular Biomedicine Group is building a cell therapy facility at its site in Shanghai and will use a GE Healthcare FlexFactory to speed the process. Release 

> Excipient maker Colorcon will build a new starch manufacturing plant near Amsterdam. Story

> ADC Bio has added a WHP cleanroom to its 6,500-square-meter bioconjugation facility at its new site in Deeside, North Wales, in the U.K. Story

Webinar

De-risking the Development of Biotherapeutics Using Early Stage In Vitro Expression and Genetic Characterisation Tools

Wednesday, July 8, 2020 | 11am EST / 8am PST

This webinar will describe strategies to mitigate risks, reduce attrition and help improve the quality and safety of your drug candidate.

Suggested Articles

Novartis and Civica Rx are patterning up to shore up supply of six key generic injectables used in acute care settings in hospitals.

Materials manufacturer SiO2 is investing $163 million to scale up its Auburn, Alabama, plant to churn out glass vials for COVID-19 vaccines.

As Regeneron moves its dual antibody into testing as a COVID-19 preventive, the company scored a hefty supply deal with the Trump administration.